Abnormally high plasma levels of vitamin B6 in children with autism not taking supplements compared to controls not taking supplements

Journal of Alternative and Complementary Medicine

Volumn 12, Issue 1, 2006, Pages 59-63

  Adams, James B ^a   George, Frank ^b   Audhya, T ^c  

^a ARIZONA STATE UNIVERSITY   (United States)

^b Integrative Medical Health Care   (United States)

^c Vitamin Diagnostics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROTRANSMITTER; PYRIDOXAL; PYRIDOXAL 5 PHOSPHATE; PYRIDOXAL KINASE; PYRIDOXINE;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ARTICLE; AUTISM; BIOTRANSFORMATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; MALE; PHOSPHORYLATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; UNITED STATES; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

AUTISTIC DISORDER; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; PYRIDOXAL KINASE; PYRIDOXAL PHOSPHATE; VITAMIN B 6;

EID: 33644782771     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2006.12.59     Document Type: Article

References (32)

1. Adams JB, Audhya T, Vogelaar E, Nutritional Abnormalities in Autism, and the Effect of Nutritional Supplementation. 2003 conference proceedings of the National Autism Society of America, Pittsburgh, PA.
2. Audhya T. Laboratory Indices of Vitamin and Mineral Deficiency in Autism. Conference Proceedings of the Fall DAN! 2002 Conference, San Diego, CA, 239-244.
3. 6 deficiency. Am J Clin Nutr 1966;18:123-133.
4. Barthelmey C, Carreau B, Leddet I, et al. Behavioral and biological effect of oral magnesium, vitamin B6, and combined magnesium-B6 administration in autistic children. Magnes Bull 1981;3;150-153.
5. 6 administration in autistic children [in French]. Neuropsychiaurie de l'Enfance 1983;31:289-301.
6. Bonisch VE. Erfahrungen with pryithosin bei hirngeschadigten kinder mit autischem syndrom [in German]. Praxis der Kinderpsychologie 1968;8:308-310.
7. Ellman G. Pyridoxine effectiveness on autistic patients at Sonoma State Hospital. Paper presented at Research Conference on Autism, San Diego, CA. November 1, 1981.
8. Findling RL, Maxwell K, Scotese-Wojtila L, et al. High-dose pyridoxine and magnesium administration in children with autistic disorder: An absence of salutary effects in a double-blind, placebo-controlled study. J Autism Dev Disorders 1997;27:467-478.
9. Garner C, Conroy E, Barthelemy CI, et al. Dopamin-beta hyrozalase(DBH) and homovanillic acid (HVA) in autistic children. J Autism Develop Disorders 1986;16:23-29.
10. Gualtieri CT, Von Bourgonndien ME, Hartx C. Pilot study of pyridozine treatment in autistic children. Paper presented at American Psychiatric Association meeting, New Orleans, LA, May 1981.
11. Heeley AF, Roberts GE. A study of tryptophan metabolism in psychotic children. Develop Med Child Neurol 1966;8:708-718.
12. 6 conbination in the treatment of residual autism in adults [in French]. Therapie 1984;39:661-669.
13. LeLord G, Muh JP, Barthelemy C, et al. Effects of pryidozine and magnesium on autistic symptoms: Initial observations. J Autism Develop Disorders 1981;11:219-230.
14. 6 Responsive Disorders in Humans. New York: Alan R. Liss, 1988.
15. Martineau J, Carreau B, Barthelemy C, Alelord O. Comparitive effects of oral B6, B6-Mg, and Mg administration on evoked potentials conditioning in autistic children. In: Rothenberger A, ed. Proceedings: Symposium on Event-Related Potentials in children, Essen, FRG 11-13 June 1982. Amsterdam: Elsevier Biomedical, 1982:411-416.
16. Martineau J, Barthelemy C, Carreau B, Lelord G. Vitamin B6, magnesium and combined B6-Mg: Therapeutic effects in childhood autism. Biol Psychiatry 1985;20:467-468.
17. Martineau J, Barthelemy C, Lelord G. Long-term effects of combined vitamin B6-magnesium administration in an autistic child. Biol Psychiatry 1986;21:511-518.
18. Martineau J, Barthelemy C, Cheliakine C, Lelord G. Brief report: An open middle-term study of combined vitamin B6-magnesium in a subgroup of autistic children selected on their sensitivity to this treatment. J Autism Dev Disord 1988;18:435-447.
19. Martineau J, Barthelemy C, Roux S, et al. Electrophysiological effects of fenfluramine or combined vitamin B6 and magnesium on children with autistic behaviour. Dev Med Child Neurol 1989;31:721-727.
20. Menage P, Thibault G, Barthelemy C, et al. CD4+ CD45RA+ T lymphocyte deficiency in autistic children: Effect of a pyridoxine-magnesium treatment. Brain Dysfunct 1999;5:326-333.
21. Moreno H, Borjas L, Arrieta A, et al. Clinical heterogeneity of the autistic syndrome: A study of 60 families. Invest Clin 1992;33:13-31.
22. Rimland B. High dosage levels of certain vitamins in the treatment of children with severe mental disorders. In: Orthomolecular Psychiatry. Hawkins D, Pauling L, eds. New York; WH Freeman, 1973:513-538.
23. Rimland B. An orthomolecular study of psychotic children. Orthomol Psychiatry 1974;3:371-377.
24. Rimland B, Callaway E, Dreyfus P. The effects of high doses of vitamin B6 on autistic children: A double-blind crossover study. Am J Psychiatry 1978;135:472-475.
25. Rimland B. Controversies in the treatment of autistic children: Vitamin and drug therapy. J Child Neurol 1988;3(Suppl): S68-S72.
26. Rimland B, Edelson SM. Parent Ratings of Behavior Effects of Biomedical Interventions. Autism Research Institute San Diego, CA: 2003.
27. Rossi P, Visconti P, Bergossi A, Balestra V. Effects of vitamin B6 and magnesium therapy in autism. Conference on the Neurobiology of Infantile Autism, Tokyo, Japan, Nov. 10-11, 1990. Online document at: www.autismwebsite.com/ari/ treatment/ b6studies.htm
28. Coleman M, Steinberg G, Tippett J, et al. A preliminary study of the effect of pyridoxine administration in a subgroup of hyperkinetic children: A double blind crossover comparison with methylphenidate. Biol Psychiatry 1979;14:741-751.
29. Tolbert L, Haigler T, Waits MM, Dennis T. Brief report: Lack of response in an autistic population to a low dose clinical trial of pyridoxine plus magnesium. J Autism Dev Disord 1993;23:193-199.
30. 6, and ascorbate in severely disturbed children. J Autism Dev Disorders 1979;9:73-82.
31. Adams JB, Holloway C. Pilot study of a moderate dose multivitamin/mineral supplement for children with autistic spectrum disorder. J Altern Complement Med 2004;10:1033-1039.
32. m): Relevance to genetic disease and polymorphisms. Am J Clin Nutr 2002;75:616-658.